Vesa-Pekka Lehto
Vesa-Pekka Lehto
University of Eastern Finland, Department of Applied Physics, Kuopio, Finland
Verified email at - Homepage
Cited by
Cited by
Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs
J Salonen, L Laitinen, AM Kaukonen, J Tuura, M Björkqvist, T Heikkilä, ...
Journal of controlled release 108 (2-3), 362-374, 2005
Mesoporous silicon in drug delivery applications
J Salonen, AM Kaukonen, J Hirvonen, VP Lehto
Journal of pharmaceutical sciences 97 (2), 632-653, 2008
Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats
LM Bimbo, M Sarparanta, HA Santos, AJ Airaksinen, E Makila, ...
ACS nano 4 (6), 3023-3032, 2010
Use of thermoanalytical methods in quantification of drug load in mesoporous silicon microparticles
VP Lehto, K Vähä-Heikkilä, J Paski, J Salonen
Journal of thermal analysis and calorimetry 80 (2), 393-397, 2005
Mesoporous silica material TUD-1 as a drug delivery system
T Heikkilä, J Salonen, J Tuura, MS Hamdy, G Mul, N Kumar, T Salmi, ...
International journal of pharmaceutics 331 (1), 133-138, 2007
Mesoporous systems for poorly soluble drugs
W Xu, J Riikonen, VP Lehto
International journal of pharmaceutics 453 (1), 181-197, 2013
Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery
T Heikkilä, J Salonen, J Tuura, N Kumar, T Salmi, DY Murzin, MS Hamdy, ...
Drug delivery 14 (6), 337-347, 2007
In vitro cytotoxicity of porous silicon microparticles: effect of the particle concentration, surface chemistry and size
HA Santos, J Riikonen, J Salonen, E Mäkilä, T Heikkilä, T Laaksonen, ...
Acta biomaterialia 6 (7), 2721-2731, 2010
Fabrication and chemical surface modification of mesoporous silicon for biomedical applications
J Salonen, VP Lehto
Chemical Engineering Journal 137 (1), 162-172, 2008
Drug permeation across intestinal epithelial cells using porous silicon nanoparticles
LM Bimbo, E Mäkilä, T Laaksonen, VP Lehto, J Salonen, J Hirvonen, ...
Biomaterials 32 (10), 2625-2633, 2011
Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles
T Laaksonen, H Santos, H Vihola, J Salonen, J Riikonen, T Heikkilä, ...
Chemical research in toxicology 20 (12), 1913-1918, 2007
Semimetallic TiO2 Nanotubes
R Hahn, F Schmidt‐Stein, J Salonen, S Thiemann, YY Song, J Kunze, ...
Angewandte Chemie International Edition 48 (39), 7236-7239, 2009
In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans
Y Sato, Y Kawashima, H Takeuchi, H Yamamoto
International journal of pharmaceutics 275 (1-2), 97-107, 2004
Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory− Huggins interaction parameter and phase diagram
K Pajula, M Taskinen, VP Lehto, J Ketolainen, O Korhonen
Molecular pharmaceutics 7 (3), 795-804, 2010
Co-delivery of a hydrophobic small molecule and a hydrophilic peptide by porous silicon nanoparticles
D Liu, LM Bimbo, E Mäkilä, F Villanova, M Kaasalainen, ...
Journal of Controlled Release 170 (2), 268-278, 2013
Carbon doping of self-organized TiO2 nanotube layers by thermal acetylene treatment
R Hahn, A Ghicov, J Salonen, VP Lehto, P Schmuki
Nanotechnology 18 (10), 105604, 2007
In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles
M Kilpeläinen, J Riikonen, MA Vlasova, A Huotari, VP Lehto, J Salonen, ...
Journal of Controlled Release 137 (2), 166-170, 2009
Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles
T Limnell, J Riikonen, J Salonen, AM Kaukonen, L Laitinen, J Hirvonen, ...
International journal of pharmaceutics 343 (1-2), 141-147, 2007
The comparison of seven different methods to quantify the amorphous content of spray dried lactose
VP Lehto, M Tenho, K Vähä-Heikkilä, P Harjunen, M Päällysaho, ...
Powder Technology 167 (2), 85-93, 2006
Multifunctional porous silicon for therapeutic drug delivery and imaging
H A Santos, L M Bimbo, VP Lehto, A J Airaksinen, J Salonen, J Hirvonen
Current drug discovery technologies 8 (3), 228-249, 2011
The system can't perform the operation now. Try again later.
Articles 1–20